Objective: To investigate the process to accept the new complementary food, by infants and to analyze the influential factors.
Method: A total of 105 infants were enrolled in this study. Early infant temperament questionnaires were answered by the mothers. The infants were given 10 times to touch new food (carrot mud), and each of their mealtime score of a 5 degrees system was recorded. The distinctions of the food acceptance were analyzed by using chi-square test. The relations between feeding patterns, sex, maternal parity, education and favor of carrot were analyzed by ANOVA and multivariate correlation analysis respectively.
Result: The infants showed a certain degree of rejection to taste the new food carrot and begin to accept after tasting for several times. By the 5(th) taste the carrot mud was accepted by most infants (87.7%). The breastfed infants were easier to accept the carrot than the formula-fed infants. There was certain degree of difference in accepting the new food between the genders. The male infants were more difficult to accept carrot than female infants. Mother's education level did not affect the baby's acceptance.
Conclusion: Many factors affect the infant's acceptance of new food. Repeatedly tasting new foods will help the infant's acceptance. Infants need at least 5 times of tasting, preferably more than 10 times, to accept new food. Attention should be paid to increase the infant's early experience on the new food. Further research should explore whether the effects of food on the early formation of the picky eating behavior of children.
Download full-text PDF |
Source |
---|
Eur J Pediatr
January 2025
Global Health and Tropical Medicine, GHTM, LA-REAL, Instituto de Higiene e Medicina Tropical, IHMT, Universidade NOVA de Lisboa, Lisbon, Portugal.
Purpose: Under-five mortality is a key public health indicator, highly responsive to preventive interventions. While global efforts have made strides in reducing mortality rates in this age group, significant disparities persist, particularly in Sub-Saharan Africa. This study aimed to systematically review the factors influencing under-five mortality in Africa, focusing on sociodemographic factors and health-related determinants.
View Article and Find Full Text PDFPediatr Res
January 2025
Division of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, USA.
Background: Unbound bilirubin (UB) was measured on day 5 ± 1 in 1101 ELBW newborns in the Aggressive vs Conservative Phototherapy randomized controlled trial. We accessed this dataset to quantify the UB-mediated risk of severe neurodevelopmental impairment (sNDI) in extremely low birthweight (ELBW) newborns.
Methods: UB levels were standardized within laboratories as z-score percentiles.
Pediatr Cardiol
January 2025
Division of Pediatric Cardiology, Department of Pediatrics, Hasbro Children's Hospital, The Warren Alpert Medical School at Brown University, Providence, RI, USA.
Prenatal diagnosis of congenital heart disease requiring early cardiac catheterization or surgical intervention enables optimal delivery planning for appropriate postnatal cardiovascular intervention and care. This allows for improved morbidity and mortality. Prior national data reported prenatal diagnosis rates of 32% for congenital heart disease requiring intervention in infants in the first 6 months of life in the New England region.
View Article and Find Full Text PDFSci Rep
January 2025
Global Vaccines and Anti-infectives Medical Affairs, Pfizer, Collegeville, PA, USA.
Tick-borne encephalitis (TBE) is an increasing health threat in Sweden and elsewhere in Europe. TBE vaccination is commonly recommended in Sweden, but limited data are available on uptake, effectiveness, and impact of TBE vaccination. General population surveys conducted in 2019-2022 were used to estimated TBE vaccine uptake.
View Article and Find Full Text PDFPediatr Surg Int
January 2025
Department of Surgery, St. Jude Children's Research Hospital, MS 133, 262 Danny Thomas Place, Memphis, TN, 38105, USA.
Purpose: Adrenocortical carcinoma (ACC) is a rare, aggressive pediatric malignancy. Advanced ACC requires multimodal treatment, including surgery and systemic chemotherapy including cisplatin, etoposide, doxorubicin, and mitotane. This is associated with significant gastrointestinal toxicity, resulting in many patients being unable to complete scheduled therapy.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!